title: Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.
authors.affiliation: Neuroscience, Emory Neurophysiologic Institute, Los Angeles, CA, USA.
authors.forename: Hamlin
authors.initials: H
authors.lastname: Emory
authors.affiliation: Neuroscience, Emory Neurophysiologic Institute, Los Angeles, CA, USA nemizrahi@gmail.com.
authors.forename: Neptune
authors.initials: N
authors.lastname: Mizrahi
mesh_terms: D000328:Adult; D003866:Depressive Disorder / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000000981:diagnostic imaging / Q000523:psychology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D014191:Tranylcypromine / Q000627:therapeutic use*
chemical_list: D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D017367:Selective Serotonin Reuptake Inhibitors; D014191:Tranylcypromine
keywords: absolute power; low resolution electromagnetic tomography; monoamine oxidase inhibitors; quantitative electroencephalography; type 1 diabetes